Remove Blog Remove Clinic Remove Management Remove Medical Specialty
article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law

As originally proposed, this new Committee could be convened in conjunction with the existing medical specialty area-focused advisory committees, akin to the Drug Safety and Risk Management Advisory Committee. those reviewed by the CDER Division of Rare Diseases and Medical Genetics).

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. Visit the ABIM Blog for reports of prior meetings.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

Visit the ABIM Blog for reports of prior meetings. This is now being reviewed by the American Board of Medical Specialties, which oversees ABIM. ABIM’s website features expansive sections on research related to assessment and clinical outcomes. The following is a summary of the spring meeting.